NOCILNSENOCIL Limited· Chemicals - SpecialityMediumPositive
Announced Fri, 3 Apr · 15:31 IST

NOCIL Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.

Major Capex Above 10pct NetworthCapex & Operations View source PDF

NOCIL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹163.89
prior close
₹165.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-2.1-1.9-1.7-1.8+0.9+0.5+2.5+3.5+6.8+12.6+14.2-5.2+10.3
Up moveDown movePending
AI summary

NOCIL Limited has informed exchanges that its Rs 250 crore capital expenditure project for capacity enhancement of Rubber Chemicals at Dahej has progressed to trial batch production stage. The company has started trial runs after completing initial phases of the expansion. Samples from these trial batches will now be sent to customers for approval before commercial production begins. The company has committed to separately informing the exchanges once commercial production commences. This is an update to their earlier disclosure from March 2024 regarding this expansion.

Likely market impact

The progression to trial batches signals that the Dahej capacity expansion is on track, which could boost NOCIL's future revenue and earnings potential once commercial production begins. This is a positive operational update for shareholders.